Cancer risk in adherent users of polyurethane foam-containing CPAP devices for sleep apnoea

Sustained and adherent CPAP therapy of obstructive sleep apnoea using Philips Respironics devices containing polyester-based polyurethane foam, was not associated with an increased risk of cancer after a median follow-up time of 7.2 years https://bit.ly/3vBpUQE

Detalles Bibliográficos
Autores principales: Justeau, Grégoire, Gervès-Pinquié, Chloé, Jouvenot, Marie, Pigeanne, Thierry, Launois, Sandrine, Leclair-Visonneau, Laurene, Masson, Philippe, Bizieux-Thaminy, Acya, Bailly, Sébastien, Meslier, Nicole, Sabil, Abdelkebir, Racineux, Jean-Louis, Trzepizur, Wojciech, Gagnadoux, Frédéric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280448/
https://www.ncbi.nlm.nih.gov/pubmed/35595314
http://dx.doi.org/10.1183/13993003.00551-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280448/
https://www.ncbi.nlm.nih.gov/pubmed/35595314
http://dx.doi.org/10.1183/13993003.00551-2022

Ejemplares similares